Thermo Fisher Scientific, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8835561023
USD
494.07
24.44 (5.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
11,005.00
12,215.00
11,122.00
10,855.00
10,364.00
11,395.00
10,598.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11,005.00
12,215.00
11,122.00
10,855.00
10,364.00
11,395.00
10,598.00
Raw Material Cost
6,560.00
7,538.00
6,530.00
6,433.00
6,119.00
6,928.00
6,255.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
450.00
474.00
414.00
471.00
303.00
384.00
424.00
Selling and Distribution Expenses
2,138.00
1,866.00
2,092.00
2,122.00
2,063.00
1,825.00
2,081.00
Other Expenses
-11.40
-11.70
-6.80
-11.90
3.90
-1.00
-7.80
Total Expenditure (Excl Depreciation)
9,034.00
9,761.00
8,968.00
8,907.00
8,524.00
9,127.00
8,682.00
Operating Profit (PBDIT) excl Other Income
1971
2454
2154
1948
1840
2268
1916
Other Income
216.00
263.00
202.00
275.00
128.00
263.00
245.00
Operating Profit (PBDIT)
2,923.00
3,444.00
3,017.00
2,908.00
2,673.00
3,273.00
2,901.00
Interest
450.00
474.00
414.00
471.00
303.00
384.00
424.00
Exceptional Items
-3.00
-89.00
-117.00
-43.00
-45.00
-205.00
5.00
Gross Profit (PBDT)
4,445.00
4,677.00
4,592.00
4,422.00
4,245.00
4,467.00
4,343.00
Depreciation
736.00
727.00
661.00
685.00
705.00
742.00
740.00
Profit Before Tax
1,734.00
2,154.00
1,826.00
1,709.00
1,620.00
1,941.00
1,742.00
Tax
70.00
153.00
207.00
92.00
95.00
150.00
99.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,651.00
1,965.00
1,616.00
1,617.00
1,507.00
1,830.00
1,630.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,651.00
1,965.00
1,616.00
1,617.00
1,507.00
1,830.00
1,630.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.00
5.00
5.00
2.00
4.00
-6.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,656.00
1,970.00
1,621.00
1,619.00
1,511.00
1,824.00
1,630.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
51,934.00
53,407.00
51,018.00
50,512.00
49,390.00
49,584.00
48,992.00
Earnings per share (EPS)
4.43
5.21
4.28
4.28
3.98
4.78
4.24
Diluted Earnings per share
4.43
5.21
4.28
4.28
3.98
4.78
4.24
Operating Profit Margin (Excl OI)
17.91%
20.09%
19.37%
17.95%
17.75%
19.9%
18.08%
Gross Profit Margin
22.44%
23.59%
22.36%
22.05%
22.43%
23.55%
23.42%
PAT Margin
15.0%
16.09%
14.53%
14.9%
14.54%
16.06%
15.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -9.91% vs 9.83% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -15.94% vs 21.53% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -14.90% vs 13.00% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -5.06% vs 14.49% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Thermo Fisher Scientific, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
11,005.00
11,164.00
-159.00
-1.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
11,005.00
11,164.00
-159.00
-1.42%
Raw Material Cost
6,560.00
5,242.00
1,318.00
25.14%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
450.00
104.00
346.00
332.69%
Selling and Distribution Expenses
2,138.00
3,740.00
-1,602.00
-42.83%
Other Expenses
-11.40
66.30
-77.70
-117.19%
Total Expenditure (Excl Depreciation)
9,034.00
9,749.00
-715.00
-7.33%
Operating Profit (PBDIT) excl Other Income
1,971.00
1,415.00
556.00
39.29%
Other Income
216.00
93.00
123.00
132.26%
Operating Profit (PBDIT)
2,923.00
2,311.00
612.00
26.48%
Interest
450.00
104.00
346.00
332.69%
Exceptional Items
-3.00
45.00
-48.00
-106.67%
Gross Profit (PBDT)
4,445.00
5,922.00
-1,477.00
-24.94%
Depreciation
736.00
803.00
-67.00
-8.34%
Profit Before Tax
1,734.00
1,449.00
285.00
19.67%
Tax
70.00
372.00
-302.00
-81.18%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,651.00
1,077.00
574.00
53.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,651.00
1,077.00
574.00
53.30%
Share in Profit of Associates
0
0
0.00
Minority Interest
5.00
0.00
5.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,656.00
1,077.00
579.00
53.76%
Equity Capital
0
0
0.00
Face Value
1.00
0.00
0.00
Reserves
51,934.00
52,061.00
-127.00
-0.24%
Earnings per share (EPS)
4.43
0.62
3.81
614.52%
Diluted Earnings per share
4.43
0.62
3.81
614.52%
Operating Profit Margin (Excl OI)
17.91%
12.67%
0.00
5.24%
Gross Profit Margin
22.44%
20.17%
0.00
2.27%
PAT Margin
15.00%
9.65%
0.00
5.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,100.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -9.91% vs 9.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6.18% vs 0.18% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 165.60 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -15.94% vs 21.53% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.60% vs 13.52% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 270.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.90% vs 13.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6.37% vs -0.43% in Mar 2025

Quarterly - Interest
Interest 45.00 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -5.06% vs 14.49% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 48.51% vs -16.53% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.91%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025